Follow
Mengtian Du
Mengtian Du
Other namesMandy Du
Analysis Group
Verified email at analysisgroup.com
Title
Cited by
Cited by
Year
Factor structure of cognition and functional capacity in two studies of schizophrenia and bipolar disorder: Implications for genomic studies.
PD Harvey, M Aslan, M Du, H Zhao, LJ Siever, A Pulver, JM Gaziano, ...
Neuropsychology 30 (1), 28, 2016
432016
Biomarker signatures of sickle cell disease severity
M Du, S Van Ness, V Gordeuk, SM Nouraie, S Nekhai, M Gladwin, ...
Blood Cells, Molecules, and Diseases 72, 1-9, 2018
302018
Consistency of recall for deployment-related traumatic brain injury
ML Alosco, M Aslan, M Du, J Ko, L Grande, SP Proctor, J Concato, ...
The Journal of Head Trauma Rehabilitation 31 (5), 360-368, 2016
242016
Patterns of multi-domain cognitive aging in participants of the Long Life Family Study
P Sebastiani, SL Andersen, B Sweigart, M Du, S Cosentino, ...
Geroscience 42, 1335-1350, 2020
212020
Digitally generated trail making test data: analysis using hidden Markov modeling
M Du, SL Andersen, S Cosentino, RM Boudreau, TT Perls, P Sebastiani
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 14 (1 …, 2022
62022
Association between apoe alleles and change of neuropsychological tests in the long life family study
M Du, SL Andersen, N Schupf, MF Feitosa, MS Barker, TT Perls, ...
Journal of Alzheimer's Disease 79 (1), 117-125, 2021
62021
Slower decline in processing speed is associated with familial longevity
SL Andersen, M Du, S Cosentino, N Schupf, AL Rosso, TT Perls, ...
Gerontology 68 (1), 17-29, 2022
42022
Systematic Literature Review of Key Outcomes Used to Assess Adjunctive Treatments for Parkinson’s Disease
RW A. Thach, M. Zichlin, M. Peddle, M. Du, A. Lerner, N. Kirson, A. Bowling ...
Movement Disorders 37 (suppl 2), 2022
32022
Bayesian variable selection utilizing posterior probability credible intervals
M Du, SL Andersen, TT Perls, P Sebastiani
medRxiv, 2021.01. 13.21249759, 2021
12021
Numbers Needed to Treat and Costs Per Improved Outcome Among Treatments for Myasthenia Gravis
T Hughes, C Qi, J Wang, H Yang, D Gelinas, E Brauer, M Du, R Sun, ...
Neurology 99 (23_Supplement_2), S38-S39, 2022
2022
EE62 The Societal Burden of Bardet-Biedl Syndrome in the United States
U Mallya, C Huber, ML Zichlin, M Du, H Wang, PI Neumann, N Kirson
Value in Health 25 (12), S65, 2022
2022
EE121 Numbers Needed to Treat and Costs per Improved Outcome Among Treatments for Myasthenia Gravis
C Qi, J Wang, H Yang, D Gelinas, E Brauer, M Du, R Sun, G Phillips
Value in Health 25 (7), S358, 2022
2022
Bayesian modeling of neuropsychological test scores
M Du
Boston University, 2021
2021
Early Differences in Cognition Associated With Familial Longevity and ApoE Genotype Using Digital Technology
S Andersen, M Du, N Roth, M Wojczynski, B Thyagarajan, T Perls, ...
Innovation in Aging 4 (Supplement_1), 656-657, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–14